Though biologic medications have improved the treatment landscape by providing the solution to many unmet medical needs, biologics cost much more than small-molecule chemical medications. Biosimilars ...

Dr Sonia T. Oskouei focuses on automatic substitution in both the pharmacy setting and in patients’ health plans. Sonia T. Oskouei, PharmD, BCMAS, DPLA: The impact of interchangeability designation on ...

Please provide your email address to receive an email when new articles are posted on . Poherdy (pertuzumab-dpzb, Shanghai Henlius Biologics Co.), a HER2 receptor antagonist and biosimilar to ...

When US regulators approved a new drug called Zarxio in March, it became the first FDA-approved biosimilar: a "copy" of a medication made from living things. Drugs derived from biological substances ...

Since the focus of pharmaceutical research has shifted from oral, small molecule medications (pills) to biologics (injectables derived from living sources) the price of new drugs has soared.

President Joe Biden’s budget proposal for fiscal 2025 includes a proposal that would allow pharmacy substitution of biosimilar drugs for the reference product, even if they are not designated as ...

Biosimilars have been quietly moderating drug prices in the background, Bernstein analyst Ronny Gal said in a recent report. Now, armed with their first biosimilar green light of 2021, Biocon and ...